1. Home
  2. SLRX vs ESTA Comparison

SLRX vs ESTA Comparison

Compare SLRX & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • ESTA
  • Stock Information
  • Founded
  • SLRX N/A
  • ESTA 2004
  • Country
  • SLRX United States
  • ESTA Costa Rica
  • Employees
  • SLRX N/A
  • ESTA N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • ESTA Industrial Specialties
  • Sector
  • SLRX Health Care
  • ESTA Health Care
  • Exchange
  • SLRX Nasdaq
  • ESTA Nasdaq
  • Market Cap
  • SLRX 3.6M
  • ESTA 1.1B
  • IPO Year
  • SLRX N/A
  • ESTA 2018
  • Fundamental
  • Price
  • SLRX $4.16
  • ESTA $38.83
  • Analyst Decision
  • SLRX
  • ESTA Strong Buy
  • Analyst Count
  • SLRX 0
  • ESTA 6
  • Target Price
  • SLRX N/A
  • ESTA $57.00
  • AVG Volume (30 Days)
  • SLRX 441.7K
  • ESTA 276.9K
  • Earning Date
  • SLRX 11-13-2025
  • ESTA 11-06-2025
  • Dividend Yield
  • SLRX N/A
  • ESTA N/A
  • EPS Growth
  • SLRX N/A
  • ESTA N/A
  • EPS
  • SLRX N/A
  • ESTA N/A
  • Revenue
  • SLRX N/A
  • ESTA $177,418,000.00
  • Revenue This Year
  • SLRX N/A
  • ESTA $28.32
  • Revenue Next Year
  • SLRX N/A
  • ESTA $24.16
  • P/E Ratio
  • SLRX N/A
  • ESTA N/A
  • Revenue Growth
  • SLRX N/A
  • ESTA 17.22
  • 52 Week Low
  • SLRX $3.64
  • ESTA $26.56
  • 52 Week High
  • SLRX $108.00
  • ESTA $50.85
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 51.26
  • ESTA 44.87
  • Support Level
  • SLRX $3.84
  • ESTA $38.50
  • Resistance Level
  • SLRX $4.52
  • ESTA $41.52
  • Average True Range (ATR)
  • SLRX 0.38
  • ESTA 2.17
  • MACD
  • SLRX -0.17
  • ESTA -0.17
  • Stochastic Oscillator
  • SLRX 23.25
  • ESTA 21.97

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Share on Social Networks: